Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-17-017496

Options or other derivatives

  • President and CSO acquired 115,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tepper Mark · President and CSO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-03-01 Grant or award : show line 1 in the form Stock Option(right to buy) +115,000 $9.05 2027-03-01 115,000 115,000 D
Loading xslF345X03/doc4.xml…